Medtronic and Samsung Electronics America are forming a broad-based strategic alliance to accelerate the development of digital health solutions for the millions of people suffering from chronic pain, movement disorders, incontinence and other conditions.
Here are six things to know:
1. These solutions will be helpful for people who could benefit from neuromodulation therapy.
2. People with these conditions, as well as their healthcare providers, need convenient access to mobile technology to better manage their health.
3. Medtronic is developing a range of future solutions that will enhance and help deliver personalized patient care and improve healthcare outcomes.
4. This alliance will leverage Samsung's deep understanding of consumer technology and mobility to develop advanced tools, based on the Android operating system, aimed at improving how patients and physicians interact with and receive data from Medtronic's clinically-proven neuromodulation systems.
5. By integrating neuromodulation therapies with Samsung technology, Medtronic seeks to deliver real-time health data to physicians and patients so they can more effectively manage the therapy, track symptoms and wirelesly monitor data received from Medtronic devices.
6. In the future, Medtronic and Samsung intend to focus on enabling patients implanted with neuromodulation therapies to use consumer electronics, such as smart phones, wearbles or tablets, and to securely and wirelessly transmit real-time data from their device to their physicians.